Skip to content
← Full study record

NCT01413178 · MORE INFO

Limitations, agreements, and source contact

A Randomized Trial to Compare Busulfan + Melphalan 140 mg/m2 With Melphalan 200 mg/m2 as Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma · Source last updated 2020-04-21

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
point Of Contact
email
mqazilba@mdanderson.org
organization
U.T. MD Anderson Cancer Center
phone
713-745-3219
title
Dr. Muzaffar H. Qazilbash / Stem Cell Transplantation and Cellular Therapy
Complete source fields
certain Agreement
pi Sponsor Employee
true
point Of Contact
email
mqazilba@mdanderson.org
organization
U.T. MD Anderson Cancer Center
phone
713-745-3219
title
Dr. Muzaffar H. Qazilbash / Stem Cell Transplantation and Cellular Therapy

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice